000 02386 a2200637 4500
005 20250518044739.0
264 0 _c20200615
008 202006s 0 0 eng d
022 _a2473-9537
024 7 _a10.1182/bloodadvances.2018030262
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChartomatsidou, Elisavet
245 0 0 _aInhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia.
_h[electronic resource]
260 _bBlood advances
_c06 2019
300 _a1891-1896 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenine
_xanalogs & derivatives
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aB-Lymphocytes
_xdrug effects
650 0 4 _aBridged Bicyclo Compounds, Heterocyclic
_xpharmacology
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aDrug Synergism
650 0 4 _aEnhancer of Zeste Homolog 2 Protein
_xantagonists & inhibitors
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHistones
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIndazoles
_xpharmacology
650 0 4 _aIndoles
_xpharmacology
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xblood
650 0 4 _aPiperidines
650 0 4 _aPurines
_xpharmacology
650 0 4 _aPyrazoles
_xpharmacology
650 0 4 _aPyridones
_xpharmacology
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aQuinazolinones
_xpharmacology
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSulfonamides
_xpharmacology
650 0 4 _aTumor Microenvironment
_xdrug effects
700 1 _aNtoufa, Stavroula
700 1 _aKotta, Konstantia
700 1 _aRovida, Alessandra
700 1 _aAkritidou, Maria Anna
700 1 _aBelloni, Daniela
700 1 _aFerrero, Elisabetta
700 1 _aTrangas, Theoni
700 1 _aStavroyianni, Niki
700 1 _aAnagnostopoulos, Achilles
700 1 _aRosenquist, Richard
700 1 _aGhia, Paolo
700 1 _aPapakonstantinou, Nikos
700 1 _aStamatopoulos, Kostas
773 0 _tBlood advances
_gvol. 3
_gno. 12
_gp. 1891-1896
856 4 0 _uhttps://doi.org/10.1182/bloodadvances.2018030262
_zAvailable from publisher's website
999 _c29824328
_d29824328